The lymphatic system and its specific growth factor vascular endothelial growth factor C in kidney tissue and in renal cell carcinoma

BJU International

Volumn 104, Issue 1, 2009, Pages 94-99

  Voss, Martin ^a   Steidler, Annette ^a   Grobholz, Rainer ^b   Weiss, Christel ^a   Alken, Peter ^a   Michel, Maurice S ^a   Trojan, Lutz ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

Author keywords

Lymphatic vessels; Renal cell carcinoma; Vascular endothelial growth factor C

Indexed keywords

VASCULOTROPIN C;

ADULT; ARTICLE; CANCER CELL; CANCER PATIENT; CLEAR CELL CARCINOMA; CONTROLLED STUDY; EPITHELIUM CELL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CAPSULE; KIDNEY CARCINOMA; KIDNEY PARENCHYMA; LYMPH NODE METASTASIS; LYMPH VESSEL; LYMPHANGIOGENESIS; LYMPHATIC SYSTEM; MAJOR CLINICAL STUDY; PAPILLARY CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE SECTION; TUMOR VOLUME;

CARCINOMA, RENAL CELL; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY NEOPLASMS; LYMPHANGIOGENESIS; LYMPHATIC METASTASIS; LYMPHATIC VESSELS; VASCULAR ENDOTHELIAL GROWTH FACTOR C;

EID: 67650498249     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2008.08305.x     Document Type: Article

References (27)

1. Kovacs G, Akhtar M, Beckwith BJ et al. The Heidelberg classification of renal cell tumours. J Pathol 1997 183 : 131 3
2. Sleeman JP, Krishnan J, Kirkin V, Baumann P. Markers for the lymphatic endothelium: in search of the holy grail? Microsc Res Tech 2001 55 : 61 9
3. Breiteneder-Geleff S, Soleiman A, Kowalski H et al. Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium. Am J Pathol 1999 154 : 385 94
4. Wigle JT, Harvey N, Detmar M et al. An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype. EMBO J 2002 21 : 1505 13
5. Kaipainen A, Korhonen J, Mustonen T et al. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci USA 1995 92 : 3566 70
6. Jackson DG, Prevo R, Clasper S, Banerji S. LYVE-1, the lymphatic system and tumor lymphangiogenesis. Trends Immunol 2001 22 : 317 21
7. Kahn HJ, Marks A. A new monoclonal antibody, D2-40, for detection of lymphatic invasion in primary tumors. Lab Invest 2002 82 : 1255 7
8. Kaiserling E. Immunohistochemical identification of lymph vessels with D2-40 in diagnostic pathology. Pathologe 2004 25 : 362 74
9. Olofsson B, Jeltsch M, Eriksson U, Alitalo K. Current biology of VEGF-B and VEGF-C. Curr Opin Biotechnol 1999 10 : 528 35
10. Takahashi M, Yoshimoto T, Kubo H. Molecular mechanisms of lymphangiogenesis. Int J Hematol 2004 80 : 29 34 (Pubitemid 38937872)
11. Achen MG, Mann GB, Stacker SA. Targeting lymphangiogenesis to prevent tumour metastasis. Br J Cancer 2006 22 : 1355 60
12. Isaka N, Padera TP, Hagendoorn J, Fukumura D, Jain RK. Peritumor lymphatics induced by vascular endothelial growth factor-C exhibit abnormal function. Cancer Res 2004 64 : 4400 4
13. Trojan L, Rensch F, Voss M et al. The role of the lymphatic system and its specific growth factor vascular endothelial growth factor C for lymphogenic metastasis in prostate cancer. BJU Int 2006 98 : 903 6
14. Tsuchiya N, Sato K, Akao T et al. Quantitative analysis of gene expressions of vascular endothelial growth factor-related factors and their receptors in renal cell carcinoma. Tohoku J Exp Med 2001 195 : 101 13
15. Gunningham SP, Currie MJ, Han C et al. Vascular endothelial growth factor-B and vascular endothelial growth factor-C expression in renal cell carcinomas: regulation by the von Hippel-Lindau gene and hypoxia. Cancer Res 2001 61 : 3206 11
16. Baltaci S, Orhan D, Gogus C, Filiz E, Tulunay O, Gogus O. Thrombospondin-1, vascular endothelial growth factor expression and microvessel density in renal cell carcinoma and their relationship with multifocality. Eur Urol 2003 44 : 76 81 (Pubitemid 36755253)
17. Beecken WD, Bentas W, Glienke W et al. Serum angiogenic activity: diagnostic relevance in renal cell carcinoma. Eur Urol 2002 42 : 364 9
18. Shibuya M, Claesson-Welsh L. Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis. Exp Cell Res 2006 312 : 549 60
19. Cao R, Eriksson A, Kubo H, Alitalo K, Cao Y, Thyberg J. Comparative evaluation of FGF-2-, VEGF-A-, and VEGF-C-induced angiogenesis, lymphangiogenesis, vascular fenestrations, and permeability. Circ Res 2004 94 : 664 70
20. Ostalska-Nowicka D, Zachwieja J, Nowicki M, Kaczmarek E, Siwinska A, Witt M. Vascular endothelial growth factor (VEGF-C1) -dependent inflammatory response of podocytes in nephrotic syndrome glomerulopathies in children: an immunohistochemical approach. Histopathology 2005 46 : 176 83
21. Foster RR, Satchell SC, Seckley J et al. VEGF-C promotes survival in podocytes. Am J Physiol Renal Physiol 2006 291 : F196 207
22. Aulitzky WE, Beck J, Huber C et al. Nierenzellkarzinom. In Hiddemann W, Huber C, Bartram CR, Die Onkologie. Berlin : Springer, 2004 : 1185
23. Ogawa E, Takenaka K, Yanagihara K et al. Clinical significance of VEGF-C status in tumour cells and stromal macrophages in non-small cell lung cancer patients. Br J Cancer 2004 91 : 498 503 (Pubitemid 39093569)
24. Schoppmann SF, St Birner P, Stockl J et al. Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis. Am J Pathol 2002 161 : 947 56
25. Jacobsen J, Grankvist K, Rasmuson T, Bergh A, Landberg G, Ljungberg B. Expression of vascular endothelial growth factor protein in human renal cell carcinoma. BJU Int 2004 93 : 297 302 (Pubitemid 38253573)
26. Byrne AM, Bouchier-Hayes DJ, Harmey JH. Angiogenic and cell survival functions of vascular endothelial growth factor (VEGF). J Cell Mol Med 2005 9 : 777 94
27. Favier B, Alam A, Barron P et al. Neuropilin-2 interacts with VEGFR-2 and VEGFR-3 and promotes human endothelial cell survival and migration. Blood 2006 108 : 1243 50